» Authors » Gil Hakim

Gil Hakim

Explore the profile of Gil Hakim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 103
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matin S, Pierorazio P, Kleinmann N, Gore J, Shabsigh A, Hu B, et al.
J Urol . 2022 Jan; 207(4):788. PMID: 34985341
No abstract available.
2.
Matin S, Pierorazio P, Kleinmann N, Gore J, Shabsigh A, Hu B, et al.
J Urol . 2021 Dec; 207(4):779-788. PMID: 34915741
Purpose: Our goal was to evaluate long-term safety and durability of response to UGN-101, a mitomycin-containing reverse thermal gel, as primary chemoablative treatment for low-grade upper tract urothelial carcinoma. Materials...
3.
Kleinmann N, Matin S, Pierorazio P, Gore J, Shabsigh A, Hu B, et al.
Lancet Oncol . 2020 Jul; 21(6):776-785. PMID: 32631491
Background: Most patients with low-grade upper tract urothelial cancer are treated by radical nephroureterectomy. We aimed to assess the safety and activity of a non-surgical treatment using instillation of UGN-101,...
4.
Rappaport Y, Zisman A, Jeshurun-Gutshtat M, Gerassi T, Hakim G, Vinshtok Y, et al.
Urology . 2018 Jan; 114:60-65. PMID: 29307733
Objective: To assess the feasibility and the safety of a mixture instillation of TC-3 gel, a novel reverse-thermal gelation hydrogel, and botulinum toxin-A (BTX-A) for the treatment of interstitial cystitis-bladder...
5.
Donin N, Chamie K, Lenis A, Pantuck A, Reddy M, Kivlin D, et al.
Urol Oncol . 2017 Mar; 35(2):39.e1-39.e7. PMID: 28341495
Purpose: Imiquimod is a toll-like receptor agonist with proven antitumor activity as a topical treatment for skin cancer. TMX-101 (Vesimune) is a novel liquid formulation of imiquimod optimized for intravesical...